[Treatment of the pelvis after total pelvic exenteration. Experience of the Regional Paul Strauss Cancer Center of Strasbourg].
Intestinal morbidity after total pelvic exenteration presents usually as fistulae. These appear particularly if irradiation has been carried out in the pelvis or the abdomen before surgery, and particularly as a result of the types of surgery carried out in the emptied pelvis. An analysis of 92 exenterations of the pelvis of which 52 were total exenterations led us to look at how treatments in the pelvis have evolved technically and to analyse the contribution they have made to reducing the number of fistulae and obstructions found as a result of this major surgery. Making a "sac" by packing the pelvis as suggested by the pioneer of this exceptionally extensive pelvic surgery gradually has been replaced by the use of endogenous material such as the omentum and more recently by the use of absorbable synthetic materials (vicryl) which give rise to progressive reperitonealisation. The authors approve of this last way of dealing with the emptied pelvic cavity because the synthetic material is very well tolerated clinically and the polyglactine 910 mesh is not predisposed to infection when it is used to make a hammock to prevent chronic radiation enteritis by holding the small intestines out of the pelvis.
Janser
J C
JC
Département de Chirurgie Oncologique, Centre Régional de Lutte contre le Cancer Paul Strauss, Strasbourg.
Rodier
J F
JF
Rodier
D
D
D002173:Cancer Care Facilities; D003125:Colostomy / Q000592:standards; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D005602:France / Q000453:epidemiology; D005833:Genital Neoplasms, Female / Q000453:epidemiology / Q000532:radiotherapy / Q000601:surgery*; D006801:Humans; D007412:Intestinal Fistula / Q000453:epidemiology / Q000209:etiology; D010385:Pelvic Exenteration / Q000009:adverse effects / Q000379:methods* / Q000592:standards; D011183:Postoperative Complications / Q000453:epidemiology / Q000209:etiology; D011878:Radiotherapy / Q000592:standards; D015996:Survival Rate